课题基金 / 基金详情

项目摘要

项目成果

Douglas D. Boyd的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A strong body of work has implicated the cell surface urokinase receptor (u-PAR) in modulating tumor growth and progression. Elevated u-PAR levels yield increased growth while low u-PAR promotes tumor dormancy the latter protective against microenvironmental stress such as hypoxia, nutrient deprivation. The u- PAR also binds the serine protease urokinase thus increasing plasmin formation and extracellular matrix protein turnover to promote tumor cell migration/invasion. Paradoxically, diminished u-PAR-dependent proteolysis benefits thrombus-enveloped tumor cells by virtue of maintaining the integrity of the fibrin “cloaking” the tumor cells from lymphokine-activated killer cells. We have made the intriguing observation that in some colon cancer cells, clonal populations oscillate in u-PAR display between high and low cell surface density with reduced tumorigenecity segregating with the latter. Interestingly, the altered u-PAR cell surface display is posttranslational in nature. In Specific Aim #1 we will determine the prevalence of u-PAR display plasticity in colon cancer, if altered tumorigenecity/dormancy mirrors this oscillation in cell surface u-PAR density and whether the sub-population down-shifted to low u-PAR has an advantage with respect to protection from the killing activity of LAK cells. In Specific Aim # 2, we will determine whether altered glycosylation of u-PAR in the u-PARdeficient population is an initial stimulus for lysosomal degradation of the immature protein.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.molcel.2013.01.024
发表时间: 2013-04-11
期刊: MOLECULAR CELL
影响因子: 16
作者: [Chauhan, Santosh, Goodwin, Jinesh G., Chauhan, Swati, Manyam, Ganiraju, Wang, Jing, Kamat, Ashish M., Boyd, Douglas D.]
通讯作者: Boyd, Douglas D.
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region.
双蒽环霉素 (WP631) 通过干扰转录因子与染色质可及的 -148/-124 启动子区域的结合来抑制 RKO 结肠癌细胞的 uPAR 基因表达和细胞迁移。
DOI: 10.3727/096504005776404571
发表时间: 2005
期刊: Oncology research
影响因子: 3.1
作者: [Nair,RajeshR, Wang,Heng, Jamaluddin,MS, Fokt,Izabella, Priebe,Waldemar, Boyd,DouglasD]
通讯作者: Boyd,DouglasD
Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression.
结肠癌中尿激酶型纤溶酶原激活剂受体 (uPAR) 显示的可塑性产生细胞表面 uPAR 密度振荡的亚稳态亚群,这对肿瘤进展有影响。
DOI: 10.1158/0008-5472.can-05-3208
发表时间: 2006
期刊: Cancer research
影响因子: 11.2
作者: [Yang,Lin, Avila,Hector, Wang,Heng, Trevino,Jose, Gallick,GaryE, Kitadai,Yasuhiko, Sasaki,Takamitsu, Boyd,DouglasD]
通讯作者: Boyd,DouglasD
Src requirement for u-PAR expression by HGF and hypoxia
Src requirement for u-PAR expression by HGF and hypoxia
Src requirement for u-PAR expression by HGF and hypoxia
UROKINASE RECEPTOR EXPRESSION--COLON CANCER
海外基金